Literature DB >> 25463547

Acute liver failure following atorvastatin dose escalation: is there a threshold dose for idiosyncratic hepatotoxicity?

Miguel F Carrascosa1, José R Salcines-Caviedes2, M Isabel Lucena3, Raul J Andrade3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25463547     DOI： 10.1016/j.jhep.2014.11.019

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  8 in total

Review 1.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

Review 2.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

Review 3.  Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.

Authors:  Aida Ortega-Alonso; Camilla Stephens; M Isabel Lucena; Raúl J Andrade
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

4.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.

Authors:  Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

5.  The Impact of Statins before High-Risk CABG on Postoperative Multiple Organ Function.

Authors:  Jiayang Wang; Wen Yuan; Kui Zhang; Nan Liu; Dong Liu; Yujie Zhou
Journal:  Cardiol Res Pract       Date:  2020-01-14       Impact factor: 1.866

6.  Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model.

Authors:  Maedeh Hamzeh; Seyed Jalal Hosseinimehr; Ali Reza Khalatbary; Hamid Reza Mohammadi; Ayat Dashti; Fereshteh Talebpour Amiri
Journal:  Res Pharm Sci       Date:  2018-10

Review 7.  Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.

Authors:  Marina Villanueva-Paz; Laura Morán; Nuria López-Alcántara; Cristiana Freixo; Raúl J Andrade; M Isabel Lucena; Francisco Javier Cubero
Journal:  Antioxidants (Basel)       Date:  2021-03-05

8.  Huotan Jiedu Tongluo Decoction Inhibits Balloon-Injury-Induced Carotid Artery Intimal Hyperplasia in the Rat through the PERK-eIF2α-ATF4 Pathway and Autophagy Mediation.

Authors:  Tenghui Tian; Keying Yu; Miao Zhang; Xiao Shao; Liping Chang; Rui Shi; Baojin Yao; Yue Deng
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-20       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.